|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Nat Genet. 36(12):1243-1244 |
In genetic control of disease, does 'race' matter? |
Goldstein DB, Hirschhorn JN.
David B Goldstein is in the Department of Biology at Galton Labs, University College London, London, WC1E 6BT, UK. |
Publication Date: Friday, November 26, 2004
|
Click here to view MEDLINE citation |
|
More November, 2004 pharmacogenomics journal articles.- Identification of a pharmacogenetic effect by linkage disequilibrium mapping.
by Xu CF, Lewis KF, Yeo AJ, McCarthy LC, Maguire MF, Anwar Z, Danoff TM, Roses AD, Purvis IJ.
Journal: Pharmacogenomics J. 4(6):374-8
- Gene expression microarray technologies in the development of new therapeutic agents.
by Clarke PA, te Poele R, Workman P.
Journal: Eur J Cancer. 40(17):2560-91
- Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).
by Shah RR.
Journal: Br J Clin Pharmacol. 58(5):452-69
- Pharmacogenetics research network and knowledge base fourth scientific meeting.
by Davis AF, Long RM.
Journal: Pharmacogenomics J. 4(6):359-61
- CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.
by Vasconcelos GM, Struchiner CJ, Suarez-Kurtz G.
Journal: Pharmacogenomics J. 11 2004;:
- The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development.
by Walker DK.
Journal: Br J Clin Pharmacol. 58(6):601-608
- Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections.
by Wunderink RG, Waterer GW.
Journal: Infect Dis Clin North Am. 18(4):743-59, vii
- [Pharmacogenomics of the growth hormone : polymorphism of the receptor in the front line.]
by Bougnères P.
Journal: Med Sci (Paris). 20(11):964-965
- Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant.
by Randolph GP, Simon JS, Arreaza MG, Qiu P, Lachowicz JE, Duffy RA.
Journal: Pharmacogenomics J. 4(6):394-402
- Interethnic variability of ERCC2 polymorphisms.
by King CR, Yu J, Freimuth RR, McLeod HL, Marsh S.
Journal: Pharmacogenomics J. 11 2004;:
- Aggresome formation and pharmacogenetics: sulfotransferase 1A3 as a model system.
by Wang L, Yee VC, Weinshilboum RM.
Journal: Biochem Biophys Res Commun. 325(2):426-33
- Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.
by Zineh I, Gerhard T, Aquilante CL, Beitelshees AL, Beasley BN, Hartzema AG.
Journal: Pharmacogenomics J. 4(6):354-8
- Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment.
by Chong VZ, Costain W, Marriott J, Sindwani S, Knauer DJ, Wang JF, Young LT, Maccrimmon D, Mishra RK.
Journal: Pharmacogenomics J. 4(6):379-87
- Pharmacology, drug efficacy, and the individual.
by Hildebrandt AG.
Journal: Drug Metab Rev. 36(3-4):845-52
- Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.
by García-Colunga J, Vázquez-Gómez E, Miledi R.
Journal: Pharmacogenomics J. 4(6):388-93
- The role of atypical antipsychotics in glucose/insulin dysregulation and the evolving role of the psychiatrist in a new era of drug treatment options.
by Ferraioli A, Shirley KL, David P.
Journal: CNS Spectr. 9(11):849-61
- Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
by Kenna GA, McGeary JE, Swift RM.
Journal: Am J Health Syst Pharm. 61(21):2272-9
- The catechol-O-methyltransferase Val(108/158)Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
by Szegedi A, Rujescu D, Tadic A, Müller MJ, Kohnen R, Stassen HH, Dahmen N.
Journal: Pharmacogenomics J. 11 2004;:
- Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management.
by Kajinami K, Takekoshi N, Brousseau ME, Schaefer EJ.
Journal: Atherosclerosis. 177(2):219-34
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|